Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

Summary

The purpose of this research is to study alternative treatments for the skin disease pemphigus (a rare autoimmune blistering disorder of the skin) by using sirolimus, an immunosuppressive drug. Immunosuppressive drugs inhibit or prevent the activity of the immune system and are commonly used to treat autoimmune diseases, inflammatory diseases, and organ transplantation rejection.

Timeline

Start

2011-02

Primary completion

2014-10

Completion

2014-10

Drugs

Indications